SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-21-000487
Filing Date
2021-05-24
Accepted
2021-05-24 16:44:46
Documents
6
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT f10q033121_10q.htm 10-Q 585017
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10q033121_ex31z1.htm EX-31.1 8755
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10q033121_ex31z2.htm EX-31.2 8893
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10q033121_ex32z1.htm EX-32.1 3639
5 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10q033121_ex32z2.htm EX-32.2 3470
6 IMAGE f10q03312110q_1.jpg GRAPHIC 38710
  Complete submission text file 0001078782-21-000487.txt   663755
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 21955613
SIC: 2834 Pharmaceutical Preparations